Advances in Development of New Treatment for Leishmaniasis

Juliana Perrone Bezerra de Menezes, Carlos Eduardo Sampaio Guedes, Antônio Luis de Oliveira Almeida Petersen, Deborah Bittencourt Mothé Fraga, Patrícia Sampaio Tavares Veras
2015 BioMed Research International  
Leishmaniasis is a neglected infectious disease caused by several different species of protozoan parasites of the genusLeishmania. Current strategies to control this disease are mainly based on chemotherapy. Despite being available for the last 70 years, leishmanial chemotherapy has lack of efficiency, since its route of administration is difficult and it can cause serious side effects, which results in the emergence of resistant cases. The medical-scientific community is facing difficulties to
more » ... overcome these problems with new suitable and efficient drugs, as well as the identification of new drug targets. The availability of the complete genome sequence ofLeishmaniahas given the scientific community the possibility of large-scale analysis, which may lead to better understanding of parasite biology and consequent identification of novel drug targets. In this review we focus on how high-throughput analysis is helping us and other groups to identify novel targets for chemotherapeutic interventions. We further discuss recent data produced by our group regarding the use of the high-throughput techniques and how this helped us to identify and assess the potential of new identified targets.
doi:10.1155/2015/815023 pmid:26078965 pmcid:PMC4442256 fatcat:zryoinstqbdxtn2yf3ysfn7sgm